 Hepatitis virus antibodies subjects liver disease United Kingdom prevalence antibody virus evidence previous current infection agent non-A non-B hepatitis subjects United Kingdom antibody cent unselected blood donors cent patients chronic post-transfusion non-A non-B hepatitis Evidence infection cent intravenous drug abusers cent haemophiliacs commercial factor VIII concentrate infection uncommon renal units promiscuous groups sexually-transmitted disease clinics seropositivity rate primary biliary cirrhosis chronic delta hepatitis low cent patients autoimmune alcoholic liver disease cent studies Spain Italy chance reason high incidence non-A non-B hepatitis latter group patients unclear